Evolent Health Inc (EVH)

Currency in USD
9.47
+0.06(+0.58%)
Real-time Data·
EVH Scorecard
Full Analysis
Net income is expected to grow this year
Earnings results expected today
EVH is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
9.419.72
52 wk Range
7.0633.63
Key Statistics
Prev. Close
9.41
Open
9.64
Day's Range
9.41-9.72
52 wk Range
7.06-33.63
Volume
341.5K
Average Volume (3m)
2.63M
1-Year Change
-56.8%
Book Value / Share
8.13
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
EVH Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
15.31
Upside
+61.64%
Members' Sentiments
Bearish
Bullish
ProTips
Analysts anticipate sales decline in the current year

Evolent Health Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Sell
Moving Averages
Sell

Evolent Health Inc Company Profile

Evolent Health, Inc., through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company offers integrated platform for health plan administration and value-based business infrastructure. It also provides administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides holistic total cost of care management; and Machinify Auth, a software platform that leverages advances in artificial intelligence. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.

Evolent Health Inc SWOT Analysis


Oncology Cost Crisis
Evolent Health grapples with rising cancer care expenses, impacting its Performance Suite business and necessitating strategic contract renegotiations
AI-Driven Future
Explore Evolent's strategic investments in artificial intelligence, poised to create cost efficiencies and enhance competitiveness by 2025
Financial Resilience
Despite challenges, Evolent projects 2025 revenue between $2.06-2.11 billion, with analysts setting price targets ranging from $12 to $39
Market Adaptation
Delve into Evolent's efforts to navigate industry changes, including Medicare Advantage shifts and the potential for strategic acquisitions
Read full SWOT analysis

Evolent Health Inc Earnings Call Summary for Q1/2025

  • Q1 revenue beat at $483.6M, EPS missed at $0.06; stock rose 3.06% in aftermarket trading
  • Launched new oncology solutions and expanded market reach; maintains optimistic 2025 outlook
  • Revenue guidance for 2025: $2.06B-$2.11B; Q2 revenue expected $440M-$470M
  • CEO highlights strong market position in specialty condition management; largest Performance Suite pipeline in history
  • Analysts inquired about oncology cost trends and AI automation impact; company confident in strategic direction
Last Updated: 08/05/2025, 23:02
Read Full Transcript

Compare EVH to Peers and Sector

Metrics to compare
EVH
Peers
Sector
Relationship
P/E Ratio
−7.8x−1.0x−0.5x
PEG Ratio
−3.27−0.010.00
Price/Book
1.2x0.9x2.6x
Price / LTM Sales
0.5x1.3x3.3x
Upside (Analyst Target)
59.4%58.4%43.5%
Fair Value Upside
Unlock15.0%6.9%Unlock

Analyst Ratings

13 Buy
1 Hold
0 Sell
Ratings:
14 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 15.31
(+61.64% Upside)

Earnings

Latest Release
May 09, 2025
EPS / Forecast
-0.63 / 0.08
Revenue / Forecast
483.65M / 460.58M
EPS Revisions
Last 90 days

EVH Income Statement

People Also Watch

37.42
EXEL
-0.78%
25.41
CNC
+0.77%
8.24
PAGS
-0.66%
21.20
TDC
-2.93%
178.75
IQV
+0.71%

FAQ

What Stock Exchange Does Evolent Health Inc Trade On?

Evolent Health Inc is listed and trades on the New York Stock Exchange stock exchange.

What Is the Stock Symbol for Evolent Health Inc?

The stock symbol for Evolent Health Inc is "EVH."

What Is the Evolent Health Inc Market Cap?

As of today, Evolent Health Inc market cap is 1.09B.

What Is Evolent Health Inc's Earnings Per Share (TTM)?

The Evolent Health Inc EPS (TTM) is -1.22.

When Is the Next Evolent Health Inc Earnings Date?

Evolent Health Inc will release its next earnings report on 06 Aug 2025.

From a Technical Analysis Perspective, Is EVH a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Evolent Health Inc Stock Split?

Evolent Health Inc has split 0 times.

How Many Employees Does Evolent Health Inc Have?

Evolent Health Inc has 4500 employees.

What is the current trading status of Evolent Health Inc (EVH)?

As of 07 Aug 2025, Evolent Health Inc (EVH) is trading at a price of 9.47, with a previous close of 9.41. The stock has fluctuated within a day range of 9.41 to 9.72, while its 52-week range spans from 7.06 to 33.63.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.